drugset / Trial / NCT00523250
Ocular Hypotensive Efficacy of AR-102
RandomizedParallel-groupDouble-blindTreatment
Summary
A double-masked, randomized, vehicle-controlled, dose-response study assessing the safety and ocular hypotensive efficacy of AR-102 in subjects with elevated intraocular pressure. The Null hypothesis is that the ocular hypotensive efficacy of each dose of AR-102 Ophthalmic Solution will not be different from that of its vehicle.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AR-102 | Unknown | 0.003 % | Other |
| Subject | AR-102 | Unknown | 0.005 % | Other |
| Subject | AR-102 | Unknown | 0.01 % | Other |
| Subject | AR-102 | Unknown | 0.03 % | Other |